Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Oral P2Y12 Inhibitors and Drug Interactions
Author(s): Elisabetta Bigagli , Jacopo Angelini , Alessandro Mugelli , et al Added: 1 week ago

Anticoagulation

Prevention & Chronic Conditions
Cardiovascular Drug Interactions with Nirmatrelvir/Ritonavir for COVID-19
Author(s): Andrea Di Lenarda , Nicola Ferri , Massimiliano Lanzafame , et al Added: 10 months ago

COVID-19

CV Disease in Special Populations
Cardiovascular Effects of NSAIDs: A Review With a Focus on RA Patients
Author(s): Eirik Ikdahl , Anne Kerola , Eli Sollerud , et al Added: 6 months ago

Prevention & Chronic Conditions
Author(s): Byoung Geol Choi , Seung-Woon Rha , Se Yeon Choi , et al Added: 11 months ago

Anticoagulation
Michel Burnier
Research Area(s) / Expertise: Job title: Emeritus Professor of Medicine & Former Head of the Division of Nephrology and Hypertension
Prof Michel Burnier, MD, is Emeritus Professor of Medicine and former Head of the Division of Nephrology and Hypertension at the University Hospital of Lausanne, Switzerland and Invited Professor at the Medical University of Gdansk, Poland.He trained in internal medicine and nephrology in Lausanne (CH) and at the University of Colorado Health Science Center, Denver, Colorado (US). He is a member… View more
ESC HF 25: The TITRATE-HF Study
Author(s): Jasper J Brugts Added: 1 month ago
ESC HF 25 - TITRATE-HF shows 65% of patients with de novo heart failure receive guideline recommended medical therapy at 6 months in the Netherlands.Dr Jasper Brugts (Erasmus University Medical Centre, NL) joins us to discuss the outcomes from the TITRATE-HF study, which investigated adherence to the 2021 ESC guideline reccommendations for patients with heart failure with reduced ejecton fraction… View more

Guidelines & Statements

Heart Failure
Research Area(s) / Expertise:
Resistant Hypertension: An Overview
Author(s): Giacomo Buso , Claudia Agabiti-Rosei , Matteo Lemoli , et al Added: 1 year ago

Prevention & Chronic Conditions
ESC 24: STEEER-AF: Stroke Prevention & Rhythm Control Therapy
Author(s): Dipak Kotecha Added: 9 months ago
ESC Congress 2024 — Improved patient-level adherence to guideline recommendations on heart rhythm control through healthcare professional education in patients with atrial fibrillation.Investigator, Dr Dipak Kotecha (University of Birmingham, UK) joins us in London to share key findings from the STEEER-AF study (NCT04396418).This prospective, cluster-randomized international study compared two… View more

Electrophysiology & Arrhythmia

Prevention & Chronic Conditions
Unlocking the Challenges of Uncontrolled Hypertension
Author(s): Thomas Weber , Erika SW Jones , Bryan Williams Added: 12 months ago
The long term clinical implications of uncontrolled hypertension are well documented, but almost half of those with hypertension remain inadequately treated. In this symposium, our panel of three leading hypertension experts, Prof Thomas Weber (Klinikum Wels-Grieskirchen, Wels, AT), Prof Bryan Williams (University College London, London, UK) and Prof Erika Jones (University of Cape Town, Cape… View more

Prevention & Chronic Conditions